Physicians' Capital Investment Dallas, TX - 75225

Physicians' Capital Investment is categorized under in Dallas, TX and active since 2008.

Physicians' Capital Investment was established in 2008, and today employs 1 to 4, earning $5.000.000 to $9.999.999 per year. This is a business, which does work in the BOTH market, and is classified as a , under code number 5239100 by the NAICS.

If you are seeking more information, feel free to contact Pedro Juan Vergne-Morell, Chief Executive Officer at the company’s headquarters by writing to 8117 Preston Road # 400, Dallas, Texas TX 75225 or by phoning (214) 646-9821. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Physicians' Capital Investment
Contact Person: Pedro Juan Vergne-Morell, Chief Executive Officer
Address: 8117 Preston Road # 400, Dallas, Texas 75225
Phone Number: (214) 646-9821
Website Address: physcap.com
Annual Revenue (USD): $5.000.000 to $9.999.999
Founded: 2008
Location Type: Headquarters
Employee Number: 1 to 4
Business Type: B2B & B2C
Business Category:
SIC Code: 6799
NAICS Code: 5239100
Share This Business:

Physicians' Capital Investment was started in 2008 to provide professional under the SIC code 6799 and NAICS code 5239100. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $5.000.000 to $9.999.999 per annum.

Feel free to contact Pedro Juan Vergne-Morell, Chief Executive Officer for inquiries that concern Physicians' Capital Investment by calling the company number (214) 646-9821, as your correspondence is most welcome. Additionally, the physical location of the headquarters of Physicians' Capital Investment can be found at the coordinates 32.862003,-96.804264 as well as the street address 8117 Preston Road # 400 in Dallas, Texas 75225.

For its online presence, you may visit Physicians' Capital Investment’s website at physcap.com and engage with its social media outlets through on Twitter and on Facebook.